ADVERTISEMENT
Advanced Enzyme Technologies Ltd. is on track to reach its revenue target of Rs 400 crore for the current fiscal, Managing Director CL Rathi said.
This despite the company’s net profit and operating margin getting affected in the short-term due to its acquisition of the loss-making Evoxx Technologies, Rathi told BloombergQuint.
The Thane-based specialty chemicals manufacturer’s operating margin for the first three quarters of the current financial year was down to 41.1 percent from 48.1 percent from a year-ago period. Net profit for the same period was down 10 percent to Rs 63 crore.
Watch the full conversation here: